The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: A case report and literature review

Ophthalmic Surgery Lasers and Imaging Retina

Volumn 45, Issue 2, 2014, Pages 160-164

  Ahn, Seong Joon ^a,b   Kim, Ko Eun ^a,c   Woo, Se Joon ^a   Park, Kyu Hyung ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Armed Forces Capital Hospital   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BEVACIZUMAB; DEXAMETHASONE; TIMOLOL; GLUCOCORTICOID;

ADULT; ARTICLE; BIOMICROSCOPY; BLURRED VISION; CASE REPORT; CENTRAL MACULAR THICKNESS; DRUG EFFECT; ELECTRORETINOGRAM; EYE EXAMINATION; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; NIGHT BLINDNESS; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; RETINITIS PIGMENTOSA; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBCAPSULAR CATARACT; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; YOUNG ADULT; ANTIHYPERTENSIVE THERAPY; BEST CORRECTED VISUAL ACUITY; CORTICOSTEROID THERAPY; DRUG IMPLANT; ELECTRORETINOGRAPHY; IMMUNOTHERAPY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPHTHALMOLOGICAL IMPLANT; RETINA DEGENERATION; SINGLE DRUG DOSE; SLIT LAMP; OPTICAL COHERENCE TOMOGRAPHY; PHYSIOLOGY; RETINA MACULA EDEMA; REVIEW; VITREOUS BODY;

DEXAMETHASONE; DRUG IMPLANTS; ELECTRORETINOGRAPHY; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; MACULAR EDEMA; MALE; RETINITIS PIGMENTOSA; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITREOUS BODY; YOUNG ADULT;

EID: 84898629417     PISSN: 23258160     EISSN: 23258179     Source Type: Journal    
DOI: 10.3928/23258160-20140131-03     Document Type: Article

References (22)

1. Hajali M, Fishman GA, Anderson RJ. The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography. Br J Ophthalmol. 2008;92(8):1065-1068.
2. Hirakawa H, Iijima H, Gohdo T, Tsukahara S. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa. Am J Ophthalmol. 1999;128(2):185-191. (Pubitemid 29379771)
3. Fishman GA, Gilbert LD, Fiscella RG, Kimura AE, Jampol LM. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol. 1989;107(10):1445-1452. (Pubitemid 19247245)
4. Ikeda Y, Hisatomi T, Yoshida N, et al. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa . Graefes Arch Clin Exp Ophthalmol. 2012;250(6):809-814.
5. Ozdemir H, Karacorlu M, Karacorlu S. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa. Acta Ophthalmol Scand. 2005;83(2):248-251. (Pubitemid 40561839)
6. Kumagai K, Oishi A, Fujihara M, Takahashi M, Kurimoto Y. Sub-Tenon's injection of triamcinolone for optic disc neovascularization in a patient with retinitis pigmentosa. Jpn J Ophthalmol. 2009;53(4):433-435.
7. Querques G, Prascina F, Iaculli C, Noci ND. Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa. Int Ophthalmol. 2009;29(2):103-107.
8. Yuzbasioglu E, Artunay O, Rasier R, Sengul A, Bahcecioglu H. Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa. Curr Eye Res. 2009;34(3):231-237.
9. Garcia-Arumi J, Martinez V, Sararols L, Corcostegui B. Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa. Ophthalmology. 2003;110(6):1164-1169. (Pubitemid 36676649)
10. Cunha-Vaz JG, Travassos A. Breakdown of the blood-retinal barriers and cystoid macular edema. Surv Ophthalmol. 1984;28 Suppl: 485-492. (Pubitemid 14076507)
11. Fishman GA, Cunha-Vaz J, Salzano T. Vitreous fluorophotometry in patients with retinitis pigmentosa. Arch Ophthalmol. 1981;99(7):1202-1207. (Pubitemid 11087065)
12. Kuchle M, Nguyen NX, Martus P, Freissler K, Schalnus R. Aqueous flare in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 1998;236(6):426-433. (Pubitemid 28269037)
13. Mallick KS, Zeimer RC, Fishman GA, Blair NP, Anderson RJ. Transport of fluorescein in the ocular posterior segment in retinitis pigmentosa. Arch Ophthalmol. 1984;102(5):691-696. (Pubitemid 14138699)
14. Vinores SA, Kuchle M, Derevjanik NL, et al. Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization. Histol Histopathol. 1995;10(4):913-923.
15. Yoshida N, Ikeda Y, Notomi S, et al. Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology. 2013;120(1):e5-e12.
16. Yoshida N, Ikeda Y, Notomi S, et al. Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology. 2013;120(1):100-105.
17. Cox SN, Hay E, Bird AC. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol. 1988;106(9):1190-1195.
18. Heckenlively JR, Jordan BL, Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol. 1999;127(5):565-573. (Pubitemid 29215768)
19. Srour M, Querques G, Leveziel N, et al. Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2013;251(6):1501-1506.
20. Haller JA, Bandello F, Belfort R, Jr., et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117(6):1134-1146.
21. Boyer DS, Faber D, Gupta S, et al. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina. 2011;31(5):915-923.
22. Sampat KM, Garg SJ. Complications of intravitreal injections. Curr Opin Ophthalmol. 2010;21(3):178-183.